"Isolate Id","Study","Species","Organism Group","Country","State","Gender","Age Group","Speciality","Source","In / Out Patient","Year","Phenotype","MIC","breakpoint","Drug"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,"0.12","Susceptible","Ceftriaxone"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,">1","Resistant","Clindamycin"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,">1","Resistant","Erythromycin"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,"0.5","Susceptible","Levofloxacin"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,"1","Susceptible","Linezolid"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,"0.015","Susceptible","Meropenem"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,">2","Intermediate","Minocycline"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,"<=0.015","Susceptible","Penicillin"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,"0.06","Susceptible","Tigecycline"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,"0.25","Susceptible","Vancomycin"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,"0.008","Susceptible","Ceftaroline"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,"0.06","Susceptible","Daptomycin"
"1421427","Inform","Streptococcus canis","Streptococcus spp (no S. pneumo)","Portugal",NA,"Male","65 to 84 Years","Medicine ICU","INT: Cellulitis/Erysipelas","Inpatient","2016",NA,"<=0.015","Susceptible","Doripenem"
